# Barty Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/barty-medical

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.bartymedical.com
- Total disclosed funding: $44M
- Latest round: Series D (Sep 22, 2026)
- Investors on record: 10

## About

Based in Hangzhou, China and founded in 2015, Zhejiang Barty Medical Technology Co., Ltd., dba Barty Medical is a medical device company mainly engaged in the research, development, manufacturing, and sales of medical devices in the field of vascular intervention. 

In September 2026, Barty Medical closed a round of Series D+ funding from China International Capital Corporation.

Barty Medical focuses on the development of cardiovascular intervention and peripheral vascular intervention devices. The company's main products include ballon catheters, drug-coated balloon catheters, guide catheters, etc. Barty Medical also offers OEM (Original Equipment Manufacturer) services, providing customers with the design, development, and manufacturing of medical devices and component technologies.

The company generates revenue from developing and providing cardiovascular intervention and peripheral vascular intervention devices to medical institutions. The company has conducted business across China and in overseas markets including South Korea, Turkey, Malaysia, Brazil and other countries and regions.

The company will primarily use the Series D+ funding for the commercialization and clinical evidence generation of the third-generation constrained drug-coated balloon, international collaboration and global clinical data accumulation, and the development of the subsequent innovative pipeline, further accelerating the globalization of its brand and innovative technologies.

## Funding rounds

- Series D, Sep 22, 2026 — China International Capital Corporation
- Series D, Jun 10, 2026, $30M — CDF-Capital, Efung Capital, Qifeng Capital, Junxingjian Venture Capital, ZJ Biomedicine and High-end Equipment Industry Fund, Zhongyiren Capital
- Series C, Dec 14, 2023, $14M — Sinowisdom, Sunz Fund
- Series A, Jul 9, 2018 — Sunz Fund, Shenzhen Guozhong Venture Capital

## Investors

- Sunz Fund (https://capitalatlas.ai/funds/sunz-fund) — Series A, Series C
- Shenzhen Guozhong Venture Capital (https://capitalatlas.ai/funds/shenzhen-guozhong-venture-capital) — Series A
- Sinowisdom (https://capitalatlas.ai/funds/sinowisdom) — Series C
- CDF-Capital (https://capitalatlas.ai/funds/cdf-capital) — Series D
- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series D
- Qifeng Capital (https://capitalatlas.ai/funds/qifeng-capital) — Series D
- Junxingjian Venture Capital (https://capitalatlas.ai/funds/junxingjian-venture-capital) — Series D
- ZJ Biomedicine and High-end Equipment Industry Fund — Series D
- Zhongyiren Capital — Series D
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series D